![Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate]()
Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilateLip, G.; Clemens, A.; Noack, H.; Ferreira, J.; Connolly, S.; Yusuf, S. · European Heart Journal · 2013